Related Experiment Video
Updated: Jun 29, 2025
Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery
Published on: June 2, 2022
Effect of Dexmedetomidine on Oxygen and Intrapulmonary Shunt (Qs/Qt) During One-Lung Ventilation in Pediatric
Ayham Khddam1, Faten Rostom2, Mohammad Y Hajeer3
1Department of Anesthesia and Resuscitation, Children's Hospital, Damascus University, Damascus, SYR.
Insights
Dexmedetomidine improved oxygenation during one-lung ventilation (OLV) in children by increasing arterial oxygen partial pressure (PaO2) and reducing pulmonary shunt fraction (Qs/Qt). It also lowered peak inspiratory pressure (PIP).
Area of Science:
- Anesthesiology
- Pediatric Critical Care
- Thoracic Surgery
Background:
- One-lung ventilation (OLV) is crucial for thoracic surgery but can cause hypoxia in children.
- Hypoxic pulmonary vasoconstriction (HPV) is a natural defense against hypoxia during OLV.
- Dexmedetomidine's effect on HPV and subsequent oxygenation during OLV in children requires investigation.
Purpose of the Study:
- To evaluate the impact of dexmedetomidine on arterial oxygen partial pressure (PaO2) and pulmonary shunt fraction (Qs/Qt) in pediatric patients undergoing OLV.
- To assess the effect of dexmedetomidine on hemodynamic parameters and peak inspiratory pressure (PIP) during OLV.
Main Methods:
- A randomized controlled trial involving pediatric patients undergoing OLV.
- Patients received either intravenous dexmedetomidine (Dex group) or normal saline (placebo group).
- Arterial and central venous blood gases, hemodynamic data, and PIP were measured at four time points: pre-OLV, during OLV, and post-OLV.
Main Results:
- The dexmedetomidine group maintained significantly higher PaO2 values compared to the placebo group during OLV.
- Dexmedetomidine administration resulted in a lower pulmonary shunt fraction (Qs/Qt) in the OLV period.
- The Dex group exhibited lower peak inspiratory pressures (PIP) and more stable heart rates than the placebo group.
Conclusions:
- Dexmedetomidine improves oxygen transport in children undergoing OLV by enhancing PaO2 and reducing Qs/Qt.
- Dexmedetomidine can mitigate pressure-related complications by lowering PIP during OLV in pediatric patients.
Abstract:
Background One-lung ventilation (OLV) is a common ventilation technique used during thoracic surgery. It can cause serious complications in children, and hypoxic pulmonary vasoconstriction (HPV) is a protective mechanism against the resulting hypoxia. Dexmedetomidine does not affect HPV, so we will investigate its impact on the partial pressure of oxygen in arterial blood (PaO2) and pulmonary shunt fraction (Qs/Qt). Methods Children who underwent OLV were divided into two equal groups. The Dex group received 0.4 μg/kg/h of dexmedetomidine intravenously. The placebo group received normal saline. Two blood samples were taken to analyze arterial and central venous blood gasses during four time periods: T1, 10 minutes after anesthesia; T2, 10 minutes after OLV; T3, 60 minutes after OLV; and T4, 20 minutes after the end of OLV. Heart rate, mean arterial pressure (MAP), PaO2, Qs/Qt, and peak inspiratory pressure (PIP) values were recorded at these time points. Results Regarding heart rate, the Dex group remained relatively stable, whereas the placebo group showed a slight increase in T3 and T4. Concerning MAP, the Dex group had a reduction at T1 compared with the placebo group and remained similar for other points. PaO2 decreased with OLV. However, the Dex group consistently maintained higher PaO2 values than the placebo, especially in T3 and T4. Concerning Qs/Qt, the Dex group maintained lower time values than the placebo group at OLV. Regarding PIP, the Dex group had significantly lower T2 and T3 than the placebo group. Conclusion Administration of dexmedetomidine in children with OLV improves PaO2 and reduces pulmonary shunt fraction (Qs/Qt), thereby improving oxygen transport. It reduces the maximum PIP values, thereby reducing pressure-related complications.
